The parallels between COVID-19 and the Spanish flu of 1918
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20204776Keywords:
COVID-19, Spanish flu 1918, SimilaritiesAbstract
The 1918 influenza pandemic was the most severe pandemic in recent history. It was caused by an H1N1 virus with genes of avian origin. On the other hand, the ongoing COVID-19 pandemic caused by a novel coronavirus hailed by the world health organization as a “once in a century health crisis” which has led to devastating impacts to health and livelihood the world over. The prevailing situation is reminiscent of the Spanish flu where definitive cure is unavailable and the public health measures like quarantine, social distancing, hand hygiene and isolation are the only alternatives. Both these diseases are transmitted through respiratory droplets, highly contagious and target the respiratory organs. The parallels between these two events cannot be denied. The Spanish flu thrived at a time when the knowledge and availability of antivirals and vaccine development were inadequate. This article strives to highlight a little more on these two separate pandemics and observe their similarities as well as their differences.
Metrics
References
Chakraborty I, Maity P. COVID-19 outbreak: Migration, effects on society, global environment and prevention. Sci Tot Environt. 2020:138882.
Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Revista Biomedica. 2006;17(1):69-79.
Olson DR, Simonsen L, Edelson PJ, Morse SS. Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proceed Nation Acade Sci. 2005;102(31):11059-63.
Taubenberger JK. The origin and virulence of the 1918 “Spanish” influenza virus. Proceed Americ Philosophi Soc. 2006;150(1):86.
Jordan E. Epidemic influenza: A survey. Chica: Americ Medic Assoc. 1927;355.
Erkoreka A. The Spanish influenza pandemic in occidental Europe (1918–1920) and victim age. Influen Respirat Virus. 2010;4(2):81-9.
Klein HA. The Treatment of Spanish Influenza. J Americ Medic Assoc. 1918;71(18):1510.
Markel H, Lipman HB, Navarro JA, Sloan A, Michalsen JR, Stern AM et al. Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic. J Am Med Assoc 2007;298:644–54.
Humphreys M. The influenza of 1918: Evolutionary perspectives in a historical context. Evolution, medicine, and public health. 2018;2018(1):219-29.
10. Martini M, Gazzaniga V, Bragazzi NL, Barberis I. The Spanish Influenza Pandemic: a lesson from history 100 years after 1918. J Prevent Medic Hygie. 2019;60(1):E64-7.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lanc (London, England). 2020;395:497–506.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lanc. 2020;395:507–13.
13. Zarocostas J. What next for the coronavirus response?. Lanc. 2020;395:401.
International Committee on Taxonomy of Virus. Naming the 2019 Coronavirus (2020). Available at: https://talk.ictvonline.org/. Accessed on 11 Aug 2020.
Narayanan L, Pandit M, Basu S, Karmakar A, Bidhan V, Kumar H, et al. Impact of lockdown due to COVID-19 outbreak: Lifestyle changes and Public Health Concerns in India.
Wang D, Yin Y, Hu C, Liu X, Zhang X, Zhou S, et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Critic Car. 2020;24:1-9.
Singhal T. A review of coronavirus disease-2019 (COVID-19). Ind J Pediat. 2020;13:1-6.
Kim GU, Kim MJ, Ra SH, Lee J, Bae S, Jung J, et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin Microbiol Infect. 2020;26:948.e1–3.
Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S-M, Hayashi K, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis. 2020;94:154–5.
Sudharsanan N, Didzun O, Bärnighausen T, Geldsetzer P. The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries: A 9-Country Demographic. Ann Intern Med. 2020;M20-2973.
Downloads
Published
How to Cite
Issue
Section
